Results
1 -
2 of
2
(Click
here to explore results)
- Discovery of imidazo[1,2-b]pyridazine-containing TAK1 kinase inhibitors with excellent activities against multiple myeloma. Desmond Akwata, Allison L. Kempen, Jones Lamptey, Neetu Dayal, Nickolas R. Brauer, Herman O. Sintim
, RSC Med. Chem.
, 2024
, 15
, 178
- Exploring the untapped pharmacological potential of imidazopyridazines. M. Shaheer Malik, Hossa F. Alshareef, Khalid A. Alfaidi, Hissana Ather, Zainularifeen Abduljaleel, Essam M. Hussein, Ziad Moussa, Saleh A. Ahmed
, RSC Adv.
, 2024
, 14
, 3972